Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries

Creative Commons License

EMRAL R., Pathan F., Yepes Cortes C. A., El-Hefnawy M. H., Goh S., Maria Gomez A., ...Daha Fazla

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.134, ss.17-28, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 134
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.diabres.2017.07.031
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.17-28
  • Anahtar Kelimeler: IO HAT study, Insulin, Diabetes, Hypoglycemia, QUALITY-OF-LIFE, DOSING IRREGULARITIES, TYPE-1, MANAGEMENT, FREQUENCY, IMPACT, COMPLICATIONS, PRODUCTIVITY, VALIDATION, PREDICTORS
  • Ankara Üniversitesi Adresli: Evet

Özet

Aims: Hypoglycemia constitutes a significant barrier to achieving glycemic control with insulin in both type 1 and type 2 diabetes. Historically, it has been difficult to accurately verify the rates of hypoglycemia within a clinical setting and there is a need for high-quality, real-world data to ascertain the true rates of hypoglycemia in clinical practice. The global Hypoglycemia Assessment Tool (HAT) study was designed to assess the global incidence of hypoglycemia in patients with insulin-treated diabetes, and the results have indicated that the overall incidence of hypoglycemia is high, with large variations between geographical regions.